News & Features

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Study finds Spanish modified Story Memory Technique effective

February 21, 2020

The findings signal an important step toward culturally appropriate care for Spanish speakers with MS.
Learn more

Novartis seeking participants for EXCHANGE research study

February 18, 2020

The EXCHANGE study is looking at a medication for people who have advancing relapsing MS.
Learn more

Dietary interventions may slow onset of MS

February 12, 2020

Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of MS in high-risk individuals.
Learn more

Study: ‘Priming’ molecule may be key to improved MS therapies

February 05, 2020

The findings could lead to more effective treatments for people living with MS.
Learn more

Scientist shows gene therapy protection of eyesight in models of MS

January 23, 2020

The study also shows how gene therapy may be used to preserve neural circuits and protect against vision loss in the disease.
Learn more

Researchers seek participants for relapsing MS study

January 17, 2020

The purpose of the research is to develop a report to inform supporters of patient education of the real-world needs of MS patients.
Learn more

Study explores factors affecting money management skills in MS

December 18, 2019

The association of money management difficulties with depressive symptomatology is a new finding, according to researchers.
Learn more

FDA approves first generics of Gilenya

December 11, 2019

The FDA approved three applications for first generics of Gilenya.
Learn more

Study suggests gut may be involved in MS development

December 06, 2019

The gut has long been suspected to play a role in MS; researchers have identified evidence of a potential mechanism.
Learn more

Study finds Spanish modified Story Memory Technique effective

February 21, 2020

The findings signal an important step toward culturally appropriate care for Spanish speakers with MS.
Learn more

Novartis seeking participants for EXCHANGE research study

February 18, 2020

The EXCHANGE study is looking at a medication for people who have advancing relapsing MS.
Learn more

Dietary interventions may slow onset of MS

February 12, 2020

Significantly reducing dietary levels of the amino acid methionine could slow onset and progression of MS in high-risk individuals.
Learn more

Study: ‘Priming’ molecule may be key to improved MS therapies

February 05, 2020

The findings could lead to more effective treatments for people living with MS.
Learn more

Scientist shows gene therapy protection of eyesight in models of MS

January 23, 2020

The study also shows how gene therapy may be used to preserve neural circuits and protect against vision loss in the disease.
Learn more

Researchers seek participants for relapsing MS study

January 17, 2020

The purpose of the research is to develop a report to inform supporters of patient education of the real-world needs of MS patients.
Learn more

Study explores factors affecting money management skills in MS

December 18, 2019

The association of money management difficulties with depressive symptomatology is a new finding, according to researchers.
Learn more

FDA approves first generics of Gilenya

December 11, 2019

The FDA approved three applications for first generics of Gilenya.
Learn more

Study suggests gut may be involved in MS development

December 06, 2019

The gut has long been suspected to play a role in MS; researchers have identified evidence of a potential mechanism.
Learn more

Study: Early lesions point to future secondary progressive MS

November 18, 2019

The findings suggest infratentorial lesions and deep white matter lesions at year one were the strongest early predictors of secondary progressive MS at 30 years.
Learn more

Study: Molecule may slow progression of MS

November 15, 2019

Results could lead to the development of a new generation of therapies to treat this autoimmune disease.
Learn more

Depressed MS patients suffer debilitating symptoms earlier

November 13, 2019

The findings highlight the need for early recognition and treatment of depressive symptoms in patients with MS.
Learn more

Study suggests potential genetic markers of MS-related vision loss

November 01, 2019

Authors said they could serve as markers for monitoring and predicting progression and severity of MS.
Learn more

FDA approves Vumerity MS

October 31, 2019

Vumerity (diroximel fumarate) approved for the treatment of relapsing forms of MS
Learn more

Researchers: Risk factors for unemployment with MS vary by age

October 24, 2019

Findings suggest that physical symptoms and how the individual manages them are greater issues for the youngest and oldest individuals.
Learn more

Study: Oligodendrocyte cells surprise contributor to MS

October 09, 2019

The discovery suggests new avenues for devising treatments and is a vital step toward finding a cure.
Learn more

Targeting subset of T cells prevents, reverses MS in mice

October 07, 2019

If the findings bear out in human studies, targeting these rogue T cells could effectively treat MS, the researchers believe.
Learn more

Study: Neuropsychological tests useful tool for real life activity in MS

September 23, 2019

Neuropsychological assessment was found to be among the tools useful for measuring the effect of MS on everyday activities.
Learn more


Show More News